Gf Fund Management Co. Ltd. Inozyme Pharma, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,544 shares of INZY stock, worth $6,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,544
Previous 1,349
14.46%
Holding current value
$6,160
Previous $3.74 Million
62.4%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INZY
# of Institutions
97Shares Held
46MCall Options Held
13.8KPut Options Held
1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$20.6 Million0.01% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$17.9 Million5.72% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$17.1 Million0.29% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.87MShares$15.4 Million0.39% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.45MShares$13.7 Million0.19% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $160M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...